Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 104Thoracic 39Gynecologic 37Genitourinary 35Head & Neck 30Dermatologic 29Breast 28Other solid neoplasm 9CNS 5Lymphoid 4Sarcoma 3Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 27Hodgkin Disease 3Breast Neoplasms 3Recurrence 2Ovarian Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytosis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Trastuzumab 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Docetaxel 2zimberelimab 1vactosertib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1saracatinib 1sapanisertib 1relatlimab 1pertuzumab 1pemigatinib 1pembrolizumab 1palbociclib 1osimertinib 1orantinib 1omipalisib 1larotrectinib 1ipatasertib 1fludarabine phosphate 1erdafitinib 1defactinib 1dabrafenib 1copanlisib 1cediranib 1capivasertib 1binimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × pembrolizumab × Plasma cell × Clear all
NCT02393248 2023-01-06

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Incyte Corporation

Phase 1/2 Terminated
201 enrolled 71 charts
BreastGastrointestinalGynecologicMyeloidPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Myeloproliferative Disorders, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡